Fisher Asset Management LLC reduced its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 1.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 828,174 shares of the company’s stock after selling 9,481 shares during the quarter. Fisher Asset Management LLC’s holdings in Azenta were worth $40,117,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AZTA. Russell Investments Group Ltd. lifted its holdings in shares of Azenta by 9.5% in the first quarter. Russell Investments Group Ltd. now owns 4,698 shares of the company’s stock valued at $283,000 after purchasing an additional 409 shares in the last quarter. Acadian Asset Management LLC boosted its position in Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after acquiring an additional 471 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Azenta in the first quarter valued at approximately $130,000. Bayesian Capital Management LP bought a new stake in shares of Azenta in the first quarter worth $387,000. Finally, Redwood Investment Management LLC acquired a new position in Azenta during the first quarter worth $1,497,000. 99.08% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
AZTA has been the topic of several recent research reports. Evercore ISI lowered their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC lowered their target price on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $63.60.
Azenta Price Performance
Shares of AZTA stock opened at $45.76 on Wednesday. The company has a fifty day moving average price of $45.17 and a two-hundred day moving average price of $50.00. Azenta, Inc. has a one year low of $38.82 and a one year high of $69.16. The stock has a market cap of $2.24 billion, a P/E ratio of -15.41 and a beta of 1.48.
Azenta (NASDAQ:AZTA – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. Azenta’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company posted $0.13 earnings per share. As a group, equities research analysts anticipate that Azenta, Inc. will post 0.4 EPS for the current fiscal year.
Insider Activity at Azenta
In related news, Director William L. Cornog acquired 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were purchased at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the acquisition, the director now directly owns 14,755 shares in the company, valued at approximately $584,298. This trade represents a 554.32 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the sale, the chief financial officer now owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. This represents a 6.09 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,018 shares of company stock worth $126,689. Company insiders own 1.77% of the company’s stock.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- Roth IRA Calculator: Calculate Your Potential Returns
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.